imatinib mesylate has been researched along with Cancer of the Vulva in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, T; Kabashima, K; Nomura, M; Otsuka, A; Yamashita, C | 1 |
| Dummer, R; Schoenewolf, NL; Urosevic-Maiwald, M | 1 |
| Corless, CL; Downs-Kelly, E; Goldblum, JR; Heinrich, MC; Lam, MM; Rubin, BP | 1 |
3 other study(ies) available for imatinib mesylate and Cancer of the Vulva
| Article | Year |
|---|---|
Successful treatment of metastatic mucosal melanoma with a Del579 c-KIT mutation by imatinib after treatment of anti-PD-1 antibody.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Base Sequence; Female; Humans; Imatinib Mesylate; Liver Neoplasms; Lymphatic Metastasis; Melanoma; Mucous Membrane; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins c-kit; Sequence Deletion; Vulvar Neoplasms | 2019 |
Tumour heterogeneity of mucosal melanomas during treatment with imatinib.
Topics: Aged; Antineoplastic Agents; Anus Neoplasms; Benzamides; Fatal Outcome; Female; Humans; Imatinib Mesylate; Male; Melanoma; Middle Aged; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Rectal Neoplasms; Treatment Outcome; Tumor Cells, Cultured; Vulvar Neoplasms | 2011 |
Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall.
Topics: Adult; Antigens, CD34; Antineoplastic Agents; Benzamides; Diagnosis, Differential; DNA, Neoplasm; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Leiomyoma; Leiomyosarcoma; Middle Aged; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Rectal Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2006 |